Evidence-based Antiplatelet Pretreatment in Non-ST-elevation Acute Coronary Syndromes. [PDF]
Torres-Ruiz G +7 more
europepmc +1 more source
Comparative Efficacy and Safety of P2Y12 Inhibitors in Patients With Diabetes Mellitus and Coronary Artery Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Aljohani AG +13 more
europepmc +1 more source
Research progress on de-escalation strategies of dual antiplatelet therapy after acute coronary syndrome. [PDF]
Liu X, Liu J, Xu C.
europepmc +1 more source
Comment on "Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome". [PDF]
Bai Y, Liu C, Feng L.
europepmc +1 more source
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin. [PDF]
Levomäki R +3 more
europepmc +1 more source
Comparative bioavailability of a novel fixed-dose combination of ticagrelor and acetylsalicylic acid. [PDF]
Tera-Ponce S +8 more
europepmc +1 more source
Impact of Prehospital Ticagrelor Loading Dose Combined With Aspirin Dual Antiplatelet Therapy on Post-PCI TIMI Flow Grade in Patients With ST-Elevation Myocardial Infarction. [PDF]
Liu P, Cai G, Wang Y, He Q.
europepmc +1 more source
Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes. [PDF]
Abounader G +12 more
europepmc +1 more source
'Aspirin versus ticagrelor for the management after coronary revascularization - a systematic review and meta‑analysis of randomised trials'. [PDF]
Regmi DR, Regmi S, Upreti S, Gautam N.
europepmc +1 more source
Ticagrelor versus clopidogrel in STEMI post-PCI: A mixed-design meta-analysis of efficacy and safety. [PDF]
Shahid MM +11 more
europepmc +1 more source

